FDA Committee Votes Against COVID-19 Vaccine Booster for General Population

September 17th 2021, 8:35pm


The advisory committee voted against COVID-19 vaccine booster shots for individuals 16 years and older, but unanimously voted for booster shots for people 65 years and older or who are at high risk of severe COVID-19.

Reducing Disparities, Using AI, Improving Clinical Trials on Tap for PCOC 2021

September 17th 2021, 4:07pm


At the 10th anniversary meeting of Patient-Centered Oncology Care®, sessions will cover reducing disparities in cancer care, bringing clinical trials closer to the community, and expanding the scope of what the term "precision medicine" means in cancer care.

Improving Outcomes-Based Managed Entry Agreements for SMA Therapy

September 12th 2021, 12:00am


Innovative therapies for rare diseases such as spinal muscular atrophy (SMA), when paid for by public budgets in the European Union and elsewhere, are often managed by agreements between payers and drug companies, but details can be hard to discern.

Transitions of Care: Supporting Patients and Physician Partners

September 10th 2021, 7:00pm


An emphasis on transitions of care should ensure the highest level of care for patients and provide support to physicians.

A Pharmacist’s Perspective on the Evidence for Lurbinectedin

September 10th 2021, 4:00pm


David J. Reeves, PharmD, BCOP, of Butler University discusses encouraging results from a recent trial, along with safety questions about the types of patients who weren't studied but are likely to have small cell lung cancer.

Biden Administration Drug Plan Includes Value-Based Payment Ideas for Medicare

September 9th 2021, 7:53pm


The administration said it would make the results of its drug price negotiations with manufacturers, as well as its approach to value-based care models, open to a variety of payers.

Examining the Current Lack of Trust in Health Care

September 7th 2021, 4:10pm


On this episode of Managed Care Cast, we speak with one of the authors of a recent book looking at the erosion of trust in health care, the factors that influence trust, and what can be done to restore trust.

Consumer Data Transparency Is More Important Than Ever as the Battle Against COVID Rages On

September 6th 2021, 4:00pm


On January 1, CMS implemented the Hospital Price Transparency final rule, but by July, it was clear that many hospitals were noncompliant. Even with a proposed rule for penalties, requirements still only fall on certain parts of the health care industry.

Bryn Mawr’s John G. Devlin Jr, MD, Discusses Changing Times in SCLC Treatment and Research

September 6th 2021, 2:00pm


The chief of medical oncology and hematology at Bryn Mawr Hospital and associate principal investigator for Main Line Health's NCI Community Oncology Research Program discusses therapeutic advances along with ongoing challenges in enrolling patients with small cell lung cancer (SCLC) in clinical trials.

Family Caregivers of Patients With Gaucher Disease Report Lower Quality-of-Life Scores

September 4th 2021, 3:20pm


Gaucher disease is a rare metabolic condition that causes a fatty substance to build up in the organs and bones. Patients can suffer liver enlargement, anemia, and reduced platelets; they experience fatigue, bone infarctions, and permanent disability or death.